Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Toray Licenses TRK-820 to Acologix for North America
June 27, 2005
- Pharma Industry Must Be Scrapped to Rebuild Globally Competitive One: Mr Murakami
June 27, 2005
- R&D NEWS IN BRIEF
June 27, 2005
- Mr Niwa Presents His Views on Social Security Reform in Booklet
June 27, 2005
- OTC NEWS IN BRIEF
June 27, 2005
- 20 New Kit Products Added to NHI Price List
June 27, 2005
- Half of Glaucoma Patients Lack Subjective Symptoms: Survey
June 27, 2005
- FPMAJ Announces Its 2005 Report on NHI Pricing
June 27, 2005
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
June 27, 2005
- Gov't Approves 2005 White Paper on Aging Society
June 27, 2005
- MEDICAL DEVICE NEWS IN BRIEF
June 27, 2005
- Generic Substitution Only Speculation at This Point: Mr Futagawa
June 27, 2005
- REGULATORY NEWS IN BRIEF
June 27, 2005
- Chugai to Establish New Strategic Marketing Unit in July
June 27, 2005
- Healthnet to Enter Chinese Market with NDA Support Business
June 27, 2005
- More Clinical Trials Needed in Japan: PFSB Director General
June 20, 2005
- REGULATORY NEWS IN BRIEF
June 20, 2005
- Forerunner Pharma Research Created by Chugai and 2 Other Firms
June 20, 2005
- JHSF Reports Results of Activities to Support Clinical Trials
June 20, 2005
- Consolidated Sales Up 0.8% for 26 Listed Pharma Companies in FY2004
June 20, 2005
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…